Ultrasound-based micro-/nanosystems for biomedical applications
H Huang, Y Zheng, M Chang, J Song, L **a… - Chemical …, 2024 - ACS Publications
Due to the intrinsic non-invasive nature, cost-effectiveness, high safety, and real-time
capabilities, besides diagnostic imaging, ultrasound as a typical mechanical wave has been …
capabilities, besides diagnostic imaging, ultrasound as a typical mechanical wave has been …
Heating technology for malignant tumors: A review
The therapeutic application of heat is very effective in cancer treatment. Both hyperthermia,
ie, heating to 39–45° C to induce sensitization to radiotherapy and chemotherapy, and …
ie, heating to 39–45° C to induce sensitization to radiotherapy and chemotherapy, and …
[HTML][HTML] An updated systematic review on focal therapy in localized prostate cancer: what has changed over the past 5 years?
Context Focal therapy is a promising, minimally invasive strategy to selectively treat
localized prostate cancer. A previous systematic review indicated that there is growing …
localized prostate cancer. A previous systematic review indicated that there is growing …
High-intensity focused ultrasound: a review of mechanisms and clinical applications
Abstract High Intensity Focused Ultrasound (HIFU) is an emerging and increasingly useful
modality in the treatment of cancer and other diseases. Although traditional use of …
modality in the treatment of cancer and other diseases. Although traditional use of …
Cancer control outcomes following focal therapy using high-intensity focused ultrasound in 1379 men with nonmetastatic prostate cancer: a multi-institute 15-year …
Background Focal therapy aims to treat areas of cancer to confer oncological control whilst
reducing treatment-related functional detriment. Objective To report oncological outcomes …
reducing treatment-related functional detriment. Objective To report oncological outcomes …
MRI-guided focused ultrasound focal therapy for patients with intermediate-risk prostate cancer: a phase 2b, multicentre study
Background Men with grade group 2 or 3 prostate cancer are often considered ineligible for
active surveillance; some patients with grade group 2 prostate cancer who are managed …
active surveillance; some patients with grade group 2 prostate cancer who are managed …
Structured population-based prostate-specific antigen screening for prostate cancer: the European Association of Urology position in 2019
Prostate cancer (PCa) is one of the first three causes of cancer mortality in Europe.
Screening in asymptomatic men (aged 55–69 yr) using prostate-specific antigen (PSA) is …
Screening in asymptomatic men (aged 55–69 yr) using prostate-specific antigen (PSA) is …
Early-medium-term outcomes of primary focal cryotherapy to treat nonmetastatic clinically significant prostate cancer from a prospective multicentre registry
Background Focal cryotherapy can be used to treat patients with clinically significant
nonmetastatic prostate cancer to reduce side effects. Objective Early-medium-term cancer …
nonmetastatic prostate cancer to reduce side effects. Objective Early-medium-term cancer …
Medium‐term oncological outcomes in a large cohort of men treated with either focal or hemi‐ablation using high‐intensity focused ultrasonography for primary …
A Stabile, C Orczyk, F Hosking‐Jervis… - BJU …, 2019 - Wiley Online Library
Objective To report medium‐term oncological outcomes in men receiving primary focal
treatment with high‐intensity focused ultrasonography (HIFU) for prostate cancer (PC a) …
treatment with high‐intensity focused ultrasonography (HIFU) for prostate cancer (PC a) …
Contemporary treatments in prostate cancer focal therapy
Prostate cancer focal therapy is an attractive option for well-selected patients because of its
low complication profile; however, long-term oncologic outcome is still lacking and early …
low complication profile; however, long-term oncologic outcome is still lacking and early …